Janus Henderson Group’s Elevance Health ELV Stock Holding History

Janus Henderson Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$121M	Buy	413,349 +452	+0.1%	+$149K	0.06%	259
2025 Q4	$145M	Buy	412,897 +160,594	+64%	+$54.3M	0.06%	228
2025 Q3	$81.5M	Sell	252,303 -12,361	-5%	-$3.84M	0.04%	311
2025 Q2	$103M	Sell	264,664 -8,108	-3%	-$3.26M	0.05%	258
2025 Q1	$118M	Sell	272,772 -90,754	-25%	-$36.4M	0.06%	244
2024 Q4	$134M	Sell	363,526 -22,878	-6%	-$9.57M	0.07%	244
2024 Q3	$201M	Sell	386,404 -1,731	-0.4%	-$925K	0.1%	190
2024 Q2	$210M	Sell	388,135 -16,959	-4%	-$8.96M	0.11%	166
2024 Q1	$210M	Sell	405,094 -14,138	-3%	-$7.03M	0.11%	181
2023 Q4	$198M	Sell	419,232 -23,186	-5%	-$10.7M	0.12%	183
2023 Q3	$193M	Sell	442,418 -9,053	-2%	-$4.11M	0.13%	175
2023 Q2	$201M	Sell	451,471 -709	-0.2%	-$327K	0.12%	166
2023 Q1	$208M	Buy	452,180 +4,436	+1%	+$2.11M	0.14%	158
2022 Q4	$230M	Sell	447,744 -558,086	-55%	-$283M	0.16%	143
2022 Q3	$457M	Buy	1,005,830 +481,629	+92%	+$230M	0.17%	145
2022 Q2	$253M	Sell	524,201 -320,999	-38%	-$159M	0.17%	146
2022 Q1	$415M	Sell	845,200 -109,662	-11%	-$50.1M	0.2%	123
2021 Q4	$443M	Buy	954,862 +316,517	+50%	+$133M	0.18%	133
2021 Q3	$238M	Sell	638,345 -25,015	-4%	-$9.51M	0.1%	208
2021 Q2	$253M	Sell	663,360 -36,049	-5%	-$13.8M	0.11%	201
2021 Q1	$251M	Buy	699,409 +60,955	+10%	+$19.6M	0.11%	195
2020 Q4	$205M	Sell	638,454 -76,129	-11%	-$23.4M	0.1%	217
2020 Q3	$192M	Sell	714,583 -74,263	-9%	-$20M	0.1%	209
2020 Q2	$207M	Buy	788,846 +161,372	+26%	+$43.1M	0.12%	187
2020 Q1	$142M	Sell	627,474 -611,043	-49%	-$167M	0.1%	216
2019 Q4	$374M	Sell	1,238,517 -619,007	-33%	-$170M	0.19%	129
2019 Q3	$446M	Sell	1,857,524 -331,988	-15%	-$91M	0.24%	99
2019 Q2	$618M	Sell	2,189,512 -55,602	-2%	-$15.2M	0.34%	69
2019 Q1	$644M	Buy	2,245,114 +205,390	+10%	+$59.4M	0.36%	60
2018 Q4	$536M	Buy	2,039,724 +619,679	+44%	+$170M	0.34%	68
2018 Q3	$389M	Buy	1,420,045 +1,457	+0.1%	+$378K	0.21%	122
2018 Q2	$338M	Sell	1,418,588 -128,230	-8%	-$29.7M	0.19%	139
2018 Q1	$340M	Buy	1,546,818 +65,091	+4%	+$15.3M	0.2%	141
2017 Q4	$333M	Buy	1,481,727 +86,093	+6%	+$18.3M	0.2%	140
2017 Q3	$265M	Buy	1,395,634 +233,898	+20%	+$44.5M	0.17%	166
2017 Q2	$219M	Buy	1,161,736 +1,122,159	+2,835%	+$202M	0.15%	181
2017 Q1	$6.55M	Sell	39,577 -614	-2%	-$97.7K	0.05%	323
2016 Q4	$5.78M	Buy	40,191 +3,910	+11%	+$524K	0.04%	341
2016 Q3	$4.55M	Sell	36,281 -2,001	-5%	-$258K	0.03%	346
2016 Q2	$5.03M	Hold	38,282	–	–	0.04%	324
2016 Q1	$5.32M	Hold	38,282	–	–	0.04%	335
2015 Q4	$5.34M	Hold	38,282	–	–	0.04%	334
2015 Q3	$5.36M	Hold	38,282	–	–	0.05%	332
2015 Q2	$6.28M	Sell	38,282 -4,768	-11%	-$762K	0.05%	330
2015 Q1	$6.65M	Sell	43,050 -855	-2%	-$122K	0.05%	330
2014 Q4	$5.52M	Sell	43,905 -3,409	-7%	-$421K	0.04%	357
2014 Q3	$5.66M	Hold	47,314	–	–	0.05%	261
2014 Q2	$5.09M	Hold	47,314	–	–	0.05%	271
2014 Q1	$4.72M	Buy	47,314 +1,738	+4%	+$157K	0.05%	288
2013 Q4	$4.21M	Hold	45,576	–	–	0.04%	297
2013 Q3	$3.81M	Sell	45,576 -4,658	-9%	-$399K	0.04%	296
2013 Q2	$4.1M	Buy	+50,234	New	+$3.76M	0.05%	276

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Janus Henderson Group's ELV Position: Q1 2026 in Review

Janus Henderson Group increased its Elevance Health (ELV) stake by 0.11% in Q1 2026, buying an estimated $149K and bringing the position to 413,349 shares worth $121M. The position accounts for 0.06% of the portfolio, ranked #259.

Janus Henderson Group first reported a position in ELV in Q2 2013 and has held it in 52 quarters since. The position peaked at $644M in Q1 2019. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

Janus Henderson Group held 413,349 shares of Elevance Health worth $121M as of Q1 2026.
Janus Henderson Group bought 452 Elevance Health shares in Q1 2026, an estimated $149K.
Elevance Health made up 0.06% of Janus Henderson Group's portfolio in Q1 2026, its #259 holding.
Janus Henderson Group first reported a position in Elevance Health in Q2 2013 and has held it in 52 quarters since.
Janus Henderson Group's Elevance Health position peaked at $644M in Q1 2019.
1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.